173 related articles for article (PubMed ID: 25293881)
1. The contribution of common genetic variation to nicotine and cotinine glucuronidation in multiple ethnic/racial populations.
Patel YM; Stram DO; Wilkens LR; Park SS; Henderson BE; Le Marchand L; Haiman CA; Murphy SE
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):119-27. PubMed ID: 25293881
[TBL] [Abstract][Full Text] [Related]
2. Nicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups.
Murphy SE; Park SS; Thompson EF; Wilkens LR; Patel Y; Stram DO; Le Marchand L
Carcinogenesis; 2014 Nov; 35(11):2526-33. PubMed ID: 25233931
[TBL] [Abstract][Full Text] [Related]
3. UGT1A and UGT2B genetic variation alters nicotine and nitrosamine glucuronidation in european and african american smokers.
Wassenaar CA; Conti DV; Das S; Chen P; Cook EH; Ratain MJ; Benowitz NL; Tyndale RF
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):94-104. PubMed ID: 25277794
[TBL] [Abstract][Full Text] [Related]
4. Nicotine metabolism in African Americans and European Americans: variation in glucuronidation by ethnicity and UGT2B10 haplotype.
Berg JZ; Mason J; Boettcher AJ; Hatsukami DK; Murphy SE
J Pharmacol Exp Ther; 2010 Jan; 332(1):202-9. PubMed ID: 19786624
[TBL] [Abstract][Full Text] [Related]
5. The contribution of common UGT2B10 and CYP2A6 alleles to variation in nicotine glucuronidation among European Americans.
Bloom AJ; von Weymarn LB; Martinez M; Bierut LJ; Goate A; Murphy SE
Pharmacogenet Genomics; 2013 Dec; 23(12):706-16. PubMed ID: 24192532
[TBL] [Abstract][Full Text] [Related]
6. UGT2B10 genotype influences nicotine glucuronidation, oxidation, and consumption.
Berg JZ; von Weymarn LB; Thompson EA; Wickham KM; Weisensel NA; Hatsukami DK; Murphy SE
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1423-31. PubMed ID: 20501767
[TBL] [Abstract][Full Text] [Related]
7. Low Cotinine Glucuronidation Results in Higher Serum and Saliva Cotinine in African American Compared to White Smokers.
Murphy SE; Sipe CJ; Choi K; Raddatz LM; Koopmeiners JS; Donny EC; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1093-1099. PubMed ID: 28264876
[No Abstract] [Full Text] [Related]
8. Nicotine Metabolism and Smoking: Ethnic Differences in the Role of P450 2A6.
Murphy SE
Chem Res Toxicol; 2017 Jan; 30(1):410-419. PubMed ID: 28092945
[TBL] [Abstract][Full Text] [Related]
9.
Sipe CJ; Koopmeiners JS; Donny EC; Hatsukami DK; Murphy SE
Cancer Epidemiol Biomarkers Prev; 2020 Aug; 29(8):1673-1678. PubMed ID: 32532831
[TBL] [Abstract][Full Text] [Related]
10. Influence of UGT2B10 Genotype on Urinary Excretion of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol- N-glucuronide by African American Smokers.
Murphy SE; von Weymarn LB; Parenteau M; Stepanov I; Tiirikainen M; LeMarchand L; Park SL
Chem Res Toxicol; 2018 Mar; 31(3):168-175. PubMed ID: 29460622
[TBL] [Abstract][Full Text] [Related]
11. Variation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake.
Zhu AZ; Zhou Q; Cox LS; Ahluwalia JS; Benowitz NL; Tyndale RF
PLoS One; 2013; 8(8):e70938. PubMed ID: 23936477
[TBL] [Abstract][Full Text] [Related]
12. Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans.
Taghavi T; St Helen G; Benowitz NL; Tyndale RF
Pharmacogenet Genomics; 2017 Apr; 27(4):143-154. PubMed ID: 28178031
[TBL] [Abstract][Full Text] [Related]
13. Associations Between Genetic Ancestries and Nicotine Metabolism Biomarkers in the Multiethnic Cohort Study.
Wang H; Park SL; Stram DO; Haiman CA; Wilkens LR; Hecht SS; Kolonel LN; Murphy SE; Le Marchand L
Am J Epidemiol; 2015 Dec; 182(11):945-51. PubMed ID: 26568573
[TBL] [Abstract][Full Text] [Related]
14. Glucuronidation of nicotine and cotinine by UGT2B10: loss of function by the UGT2B10 Codon 67 (Asp>Tyr) polymorphism.
Chen G; Blevins-Primeau AS; Dellinger RW; Muscat JE; Lazarus P
Cancer Res; 2007 Oct; 67(19):9024-9. PubMed ID: 17909004
[TBL] [Abstract][Full Text] [Related]
15. Genetic determinants of CYP2A6 activity across racial/ethnic groups with different risks of lung cancer and effect on their smoking intensity.
Park SL; Tiirikainen MI; Patel YM; Wilkens LR; Stram DO; Le Marchand L; Murphy SE
Carcinogenesis; 2016 Mar; 37(3):269-279. PubMed ID: 26818358
[TBL] [Abstract][Full Text] [Related]
16. Glucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphisms.
Chen G; Giambrone NE; Dluzen DF; Muscat JE; Berg A; Gallagher CJ; Lazarus P
Cancer Res; 2010 Oct; 70(19):7543-52. PubMed ID: 20876810
[TBL] [Abstract][Full Text] [Related]
17. Effect of race and glucuronidation rates on the relationship between nicotine metabolite ratio and nicotine clearance.
Liakoni E; Tyndale RF; Jacob P; Dempsey DA; Addo N; Benowitz NL
Pharmacogenet Genomics; 2021 Jul; 31(5):97-107. PubMed ID: 33675323
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences.
Chenoweth MJ; Ware JJ; Zhu AZX; Cole CB; Cox LS; Nollen N; Ahluwalia JS; Benowitz NL; Schnoll RA; Hawk LW; Cinciripini PM; George TP; Lerman C; Knight J; Tyndale RF;
Addiction; 2018 Mar; 113(3):509-523. PubMed ID: 28921760
[TBL] [Abstract][Full Text] [Related]
19. Association of internal smoking dose with blood DNA methylation in three racial/ethnic populations.
Park SL; Patel YM; Loo LWM; Mullen DJ; Offringa IA; Maunakea A; Stram DO; Siegmund K; Murphy SE; Tiirikainen M; Le Marchand L
Clin Epigenetics; 2018 Aug; 10(1):110. PubMed ID: 30139389
[TBL] [Abstract][Full Text] [Related]
20. Nicotine glucuronidation and the human UDP-glucuronosyltransferase UGT2B10.
Kaivosaari S; Toivonen P; Hesse LM; Koskinen M; Court MH; Finel M
Mol Pharmacol; 2007 Sep; 72(3):761-8. PubMed ID: 17576790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]